Results 241 to 250 of about 4,725,282 (330)
Estudio de 258 prematuros en el primer año de la vida [PDF]
OSCAR ILLANES BENITEZ+1 more
openalex +1 more source
Plain Language Summary: This randomized trial was designed to test the effectiveness and safety of rimegepant for the acute treatment of migraine among adults in Japan. Results indicated that rimegepant was more effective than placebo, and the 75 mg dose was observed to be more effective than the 25 mg dose.
Koichi Ikeda+11 more
wiley +1 more source
Spirituality and health-related quality of life in patients with lung cancer. [PDF]
Santos EMBD+7 more
europepmc +1 more source
Lauracha (La vida en la estancia)
Joseph G. Fucilla, Otto Miguel Cione
openalex +2 more sources
Plain Language Summary: This study tested the effectiveness of rimegepant for migraine prevention in Japan. Results showed that rimegepant was more effective than placebo in reducing monthly migraine days, with very few adverse effects. These results support the previous findings from a clinical study conducted in the United States and broaden them to ...
Shigekazu Kitamura+11 more
wiley +1 more source
Social reproduction and health: contributions from Breilh and Lukács to social thinking in collective health. [PDF]
Souza DO.
europepmc +1 more source
Vida y obra de Sarmiento en síntesis cronológica de Julia Ottolenghi
Marshall R. Nason
openalex +2 more sources
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow+3 more
wiley +1 more source